TotalEnergies secures exploration license in Algeria with QatarEnergy

Jacques Aschenbroich Lead Independent Director of TotalEnergies TotalEnergies SE
Jacques Aschenbroich Lead Independent Director of TotalEnergies - TotalEnergies SE
0Comments

TotalEnergies, in collaboration with QatarEnergy, has secured the Ahara license as part of the “Algeria Bid Round 2024.” This bid round was initiated by The National Agency for the Valorization of Hydrocarbon Resources (ALNAFT) and is the first under Algeria’s hydrocarbon law No.19-13.

The Ahara license spans approximately 14,900 km² and is situated at the intersection of the Berkine and Illizi Basins. TotalEnergies will act as the operator during both the Exploration and Appraisal phases, holding a 24.5% effective interest. QatarEnergy also holds a 24.5% share, while SONATRACH retains a majority interest of 51%, as mandated by Algerian law.

Patrick Pouyanné, Chairman and CEO of TotalEnergies, stated: “TotalEnergies is delighted that its joint bid with QatarEnergy has led to the award of the Ahara license, allowing us to write a new chapter in our long-lasting partnership with SONATRACH in Exploration in Algeria.”

TotalEnergies has been active in Algeria’s energy sector through various subsidiaries involved in oil and gas exploration and production. The company operates in several fields including Tin Fouyé Tabankort, Timimoun gas fields, and Berkine Basin oil fields. In 2023, TotalEnergies produced 51 kboe/d from these interests. Additionally, TotalEnergies markets lubricants and bitumen through its subsidiaries in Algeria.

TotalEnergies operates globally across about 120 countries, focusing on providing sustainable energy solutions.



Related

Paul Hudson Chief Executive Officer Sanofi SA

Acoziborole receives key EU panel backing as single-dose treatment for sleeping sickness

Acoziborole Winthrop, a new oral treatment for sleeping sickness developed by the Drugs for Neglected Diseases initiative (DNDi) and Sanofi, has received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for…

Martin Lundstedt President and CEO at Volvo Group North America LLC Volvo Group North America LLC

Volvo announces updated share and vote count after series conversion

The number of votes in AB Volvo has changed following the conversion of 2,000,619 Series A shares into an equal number of Series B shares.

Paul Hudson Chief Executive Officer Sanofi SA

Sanofi and Regeneron’s Dupixent recommended for EU approval in young children with chronic urticaria

Sanofi and Regeneron have announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Dupixent (dupilumab) for children aged two to 11 years with…

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from EU Business Daily.